Immunization of pregnant women: Reproductive, medical and societal risks

Vaccine

Volumn 21, Issue 24, 2003, Pages 3413-3421

  Brent, Robert L ^a  

^a NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

Birth defects; Immunization; Negligence litigation; Neonatal infections; Pregnancy; Prematurity

Indexed keywords

VIRUS VACCINE;

BIRTH DEFECT; CLINICAL TRIAL; CONFERENCE PAPER; DNA VIRUS; EMOTION; GOVERNMENT; HUMAN; IMMUNIZATION; LAW SUIT; NEWBORN INFECTION; ORGANIZATION; PREGNANCY; PREMATURITY; PREVENTIVE MEDICINE; PRIORITY JOURNAL; REPRODUCTIVE HEALTH; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RNA VIRUS; THEORETICAL STUDY; VACCINATION; VIRUS INFECTION;

EID: 0037484132     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00396-7     Document Type: Conference Paper

References (49)

1. Bass J.W., Landes R.D. Neonatal rubella following maternal immunization. J. Pediatr. 98:1981;668-669. [Reply].
2. Best J.M., Banatvala J.E., Morgan-Capner P., Miller E. Fetal infection after maternal reinfection with rubella: Criteria for defining reinfection. Br. Med. J. 299:1989;773-775.
3. Bolognese R.J., Corson S.L., Fuccillo D.A., Sever J.L., Traub R. Evaluation of possible transplacental infection with rubella vaccination during pregnancy. Am. J. Gynecol. 117(7):1973;939-941.
4. Das B.D., Lakhani P., Kurtz J.B., Hunter N., Watson B.E., Cartwright K.A.et al. Congenital rubella after previous maternal immunity. Arch. Dis. Child. 65:1990;545-546.
5. Ebbin A.J., Wilson M.G., Chandor S.B., Wehrle P.F. Inadvertent rubella vaccination in pregnancy. Am. J. Obstet. Gynecol. 117(4):1973;505-512.
6. Landes R.D., Bass J.W., Millunchick E.N., Oetgen W.T. Neonatal rubella following postpartum maternal immunization. J. Pediatr. 97(3):1980;465-467.
7. Lerman S.J. Neonatal rubella following maternal immunization. J. Pediatr. 98:1981;668-669.
8. Preblud S.R., Stettler A.C., Frank J.A. Jr., Greaves W.L., Hinman A.R., Hermann K.L. Fetal risk associated with rubella vaccine. J. Am. Med. Assoc. 246(13):1981;1413-1417.
9. Zeffer K.B., Sauer M.V. Orchitis after a rubella vaccination. J. Reprod. Med. 33:1988;80-81.
10. Weibel R.E., Caserta V., Benor D.E., Evans G. Acute encephalopathy followed by permanent brain injury or death associated with further attenuated measles vaccine: a review of claims submitted to the National Vaccine Injury Compensation Program. Pediatrics. 101(3):1998;383-387.
11. Gregg N.M. Congenital cataract following German measles in the mother. Trans. Ophthalmol. Soc. Aust. 3:1941;35-46.
12. Thiersch J.B. Therapeutic abortions with a folic acid antagonist 4-aminopteroylglutamic acid (4-amino P.G. A.) administered by the oral route. Am. J. Obstet. Gynecol. 63:1952;1298-1304.
13. Warkany J., Beautry P.H., Horstein S. Attempted abortion with aminopterin (4-aminopteroylglutamic acid). Am. J. Dis. Child. 97:1959;274-281.
14. Warkany J., Schraffenberger E. Congenital malformations of the eyes induced in rats by maternal Vitamin A deficiency. Proc. Soc. Exp. Biol. Med. 57:1944;49-52.
15. Beckman D.A., Brent R.L. Teratogenesis: alcohol angiotensin converting enzyme inhibitors and cocaine. Curr. Opin. Obstet. Gynecol. 2:1990;236-245.
16. Brent R.L., Beckman D.A. Environmental teratogens. Bull. N. Y. Acad. Med. 66(2):1990;123-163.
17. Beckman DA, Brent RL. Basic principles of teratology. In: Reece EA, Hobbins JC, editors. Medicine of the fetus and mother. 2nd ed. Philadelphia, PA: Lippincott-Raven; 1999. p. 281-8 [chapter 18].
18. Brent RL, Beckman DA. Prescribed drugs therapeutic agents and fetal teratogenesis. In: Reece EA, Hobbins JC, editors. Medicine of the fetus and mother. 2nd ed. Philadelphia, PA: Lippincott-Raven; 1999. p. 289-313 [chapter 19].
19. Brent R.L. Utilization of developmental basic science principles in the evaluation of reproductive risks from pre- and post-conception environmental radiation exposures. Paper presented at the 33rd Annual Meeting of the National Council on Radiation Protection and Measurements. The Effects of Pre- and Postconception Exposure to Radiation, April 2-3, 1997, Arlington, VA. Teratology. 59:1999;182-204.
20. Centers for Disease Control (CDC). US Department of Health and Human Services: rubella vaccination during pregnancy - United States 1971-1988. MMWR Morb Mortal Wkly Rep 1989;38:289-93.
21. Brent R.L. Addressing environmentally caused human birth defects. Pediatr. Rev. 22(5):2001;153-165.
22. Brent R.L. The cause and prevention of human birth defects: What have we learned in the past 50 years? Congen. Anomal. 41:2001;3-21.
23. World Health Organization (WHO). Spontaneous and induced abortion. Technical report series report no. 461. Geneva: World Health Organization; 1970.
24. BEIR V. Committee on the Biological Effects of Ionizing Radiation Health effects of exposure to low levels of ionizing radiation. Washington, DC: National Academy Press; 1990.
25. Brent RL. Immunologic aspects of developmental biology. In: Woollam DHM, editor. Advances in teratology, vol. 1. 1966. p. 82-129.
26. Brent R.L., Averich E., Drapiewski V.A. Production of congenital malformations using tissue antibodies. I. Kidney antisera. Proc. Soc. Exp. Biol. Med. 106:1961;523-526.
27. Brent R.L., Johnson A.J., Jensen M. The production of congenital malformations using tissue antisera. VII. Yolk sac antiserum. Teratology. 4:1971;255-276.
28. Brent RL. Maternal nutrition and congenital malformations. In: Young BK, editor. The patient within the patient: problems in perinatal medicine. March of Dimes Birth Defects Foundation, vol. 21. New York: Alan R. Liss; 1985. p. 1-8.
29. Pugarelli J.E., Brent R.L., Lloyd J.B. Effects of methionine supplement on methionine incorporation in rat embryos cultured in vitro. Teratology. 60(1):1999;6-9.
30. Koszalka T.R., Andrew C.L., Brent R.L., Beckman D.A., Lloyd J.B. Amino acid requirements in the early postimplantation rat conceptus. Placental. 15:1994;311-320.
31. Brent R.L., Beckman D.A., Jensen M., Koszalka T.R. Experimental yolk sac dysfunction as a model for studying nutritional disturbances in the embryo during early organogenesis. Teratology. 41:1990;405-414.
32. Brent R.L., Fawcett L.B. Nutritional studies of the embryo during early organogenesis with normal embryos exhibiting yolk sac dysfunction. J. Pediatr. Suppl. 132(3 (Part 2)):1998;S6-S16.
33. Lloyd J.B., Brent R.L., Beckman D.A. Sources of amino acids for protein synthesis during early organogenesis in the rat. 3. Methionine incorporation. Placenta. 17:1996;629-634.
34. Beckman D.A., Lloyd J.B., Brent R.L. Investigations into mechanisms of amino acid supply to the rat embryo using whole-embryo culture. Int. J. Dev. Biol. 41:1997;315-318.
35. Beckman D.A., Pugarelli J.E., Koszalka T.R., Brent R.L., Lloyd J.B. Sources of amino acids for protein synthesis during early organogenesis in the rat. 2. Exchange with amino acid and protein pools in embryo and yolk sac. Placenta. 12:1991;37-46.
36. Hertig AT. The overall problem in man. In: Benirschke K, editor. Comparative aspects of reproductive failure. Berlin: Springer-Verlag; 1967. p. 11-41.
37. Nishimura H. Incidence of malformations in abortions. In: Fraser FC, McKusick VA, editors. Congenital malformations. Excerpta Medica International Congress Series. New York: Excerpta Medica; 1970. p. 204, 275-83.
38. Robert C.J., Lowe C.R. Where have all the conceptions gone? Lancet. 1:1975;498.
39. Brent R.L. Medicolegal aspects of teratology. J. Pediatr. 71:1967;288-298.
40. Brent R.L. Litigation-produced pain, disease and suffering: an experience with congenital malformation lawsuits. Teratology. 16:1977;1-14.
41. Brent R.L. Drugs and pregnancy: are the insert warnings too dire? Contemp. Obstet. Gynecol. 20:1982;42-49.
42. Brent R.L. The irresponsible expert witness: a failure of biomedical graduate education and professional accountability. Pediatrics. 70:1982;754-762.
43. Brent RL. Malpractice experience and issues. In: Medical-legal issues in pediatrics. Report of the 18th Ross Roundtable on Critical Approaches to Common Pediatric Problems in Collaboration with the Ambulatory Pediatric Association. Columbus, OH: Ross Laboratories; 1987. p. 20-5.
44. Brent R.L. Improving the quality of expert witness testimony. Pediatrics. 82:1988;511-513.
45. Brent R.L. Bendectin: review of the medical literature of a comprehensively studied human non-teratogen and the most prevalent tortogen-litigen. Reprod. Toxicol. 9(4):1995;337-349.
46. Brent R.L. Commentary: bringing scholarship to the courtroom: The Daubert decision and its impact on the Teratology Society. Teratology. 52:1995;225-247.
47. Huber PW, editor. Galileo's revenge: junk science in the courtroom. Basic books. New York: Harper Collins; 1991.
48. Brent RL. Review of the scientific literature pertaining to the reproductive toxicity of Bendectin. In: Faigman DL, Kaye DH, Saks MJ, Sanders J, editors. Modern scientific evidence: the law and science of expert testimony, vol. 2. St. Paul, MN: West Publishing Group; 1997. p. 373-93 [chapter 29].
49. Brent R.L. Opinion: bringing scholarship to the courtroom: The Daubert decision. Scientist. 9(24):1995;11.